Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Treatment of headache. Clin J Pain 1989;5 Suppl 2:S7-16; discussion S16-8 PMID: 2520442

Pubmed ID

2520442

Abstract

Headache is the most common complaint encountered in clinical practice. Approximately 45 million people in the United States experience chronic headaches. The management of migraine headache involves both pharmacologic and nondrug therapy. Drug therapy for migraine involves the use of abortive and prophylactic agents. Abortive agents, such as ergotamine tartrate and ketoprofen, may be used to relieve the acute attack. Prophylactic therapy is focused on reducing the frequency and severity of the attacks. beta-Adrenergic blocking agents, such as propranolol, remain the primary agents for many migraine patients, although other drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs), including ketoprofen, or calcium-channel blocking agents, such as verapamil, may be beneficial for many patients. For cluster headache and its variants, methysergide and corticosteroids are usually the drugs of choice. Patients with chronic cluster headache may achieve good results from long-term treatment with other therapies, including lithium carbonate, verapamil, and ketoprofen.

Author List

Diamond S, Freitag FG

Author

Frederick G. Freitag DO Associate Professor in the Neurology department at Medical College of Wisconsin




Scopus

2-s2.0-0024792577   2 Citations

MESH terms used to index this publication - Major topics in bold

Adult
Cluster Headache
Female
Headache
Humans
Migraine Disorders
jenkins-FCD Prod-331 a335b1a6d1e9c32173c9534e6f6ff51494143916